You May Qualify for the Gout with Flair-Ups
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout. This clinical research study is being conducted in Oradell, NJ.
See If You Qualify
Fill out the form below and we'll contact you to discuss eligibility.
Participation is voluntary. You may qualify based on specific criteria.
Why Consider Participating?
Clinical research studies help advance medical knowledge and may provide access to new treatment options.
By participating, you contribute to medical research that may help others with similar conditions in the future. Participation is voluntary, and you may withdraw at any time.
Eligibility Requirements
To participate in this research study, you must meet certain criteria.
Qualified Participants Must:
- ✓18 – 75 years old
- ✓Have gout for > 1 year
- ✓On Allopurinol at > 200mg
- ✓Have 2 or more painful flair-ups in the past 12 months
Important: Meeting these criteria does not guarantee enrollment in the study. A study coordinator will review your information and contact you if you may qualify. Final eligibility will be determined during a screening visit.
What Qualified Participants May Receive
Qualified participants may receive the following benefits.
Qualified Participants May:
- ★Free study medication
- ★No insurance required
- ★See a study doctor at no cost
Important Disclosure: Participation in this research study may involve risks. Benefits are not guaranteed and will vary by individual. A study coordinator will provide detailed information about potential risks and benefits during the screening process.
Study-Related Care
All study-related medical visits and procedures are provided at no cost to qualified participants.
Expert Medical Team
Access to board-certified physicians and experienced clinical research coordinators.
What to Expect After You Apply
Here's what happens next in the screening process
Information Review
A study coordinator will review your information to determine if you may meet the basic eligibility criteria.
Initial Contact
If you may qualify, we will contact you within 24-48 hours to ask additional questions and provide more details about the study.
Screening Visit
If you meet the initial criteria, you will be invited for a screening visit. During this visit, we will review the informed consent document, answer your questions, and conduct assessments to determine final eligibility.
Enrollment Decision
If you qualify and choose to participate, you will begin the study and receive detailed information about all study visits and procedures.
About Curalta Clinical Trials
Trusted clinical research site with over 30 years of experience
Our Credentials
- ✓Board-certified physicians
- ✓Experienced clinical research coordinators
- ✓IRB-approved protocols
- ✓HIPAA-compliant data protection
Contact Information
Phone
(551) 553-1859Location
680 Kinderkamack Rd, Suite 301
Oradell, NJ 07649
Compliance & Privacy
Your safety and privacy are our top priorities
IRB Approval
This study has been approved by an Institutional Review Board (IRB). An IRB is a group that reviews research studies to protect the rights and welfare of research participants.
HIPAA Privacy Standards
All information submitted is protected under HIPAA privacy standards. Your personal health information will be kept confidential and used only for research purposes as described in the informed consent document.
Text Message Compliance
Text messaging complies with A2P 10DLC regulations. By opting in, you agree to receive SMS messages about this research study (1-3 msgs/month). Message & data rates may apply. Reply STOP to opt out at any time. Consent to receive SMS is not required to participate in this study.
Voluntary Participation
Participation in this research study is completely voluntary. You may choose not to participate or may leave the study at any time without penalty or loss of benefits to which you are otherwise entitled.